These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 30120555)

  • 1. Catalase and nonalcoholic fatty liver disease.
    Shin SK; Cho HW; Song SE; Song DK
    Pflugers Arch; 2018 Dec; 470(12):1721-1737. PubMed ID: 30120555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impaired redox balance in peroxisomes of catalase knockout mice accelerates nonalcoholic fatty liver disease through endoplasmic reticulum stress.
    Hwang I; Uddin MJ; Pak ES; Kang H; Jin EJ; Jo S; Kang D; Lee H; Ha H
    Free Radic Biol Med; 2020 Feb; 148():22-32. PubMed ID: 31877356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.
    Chen G; Ni Y; Nagata N; Xu L; Ota T
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
    Serviddio G; Bellanti F; Vendemiale G
    Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of catalase promotes non-alcoholic fatty liver via oxidative stress and mitochondrial dysfunction in diet-induced obese mice.
    Shin SK; Cho HW; Song SE; Bae JH; Im SS; Hwang I; Ha H; Song DK
    Pflugers Arch; 2019 Jun; 471(6):829-843. PubMed ID: 30617744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation.
    Farzanegi P; Dana A; Ebrahimpoor Z; Asadi M; Azarbayjani MA
    Eur J Sport Sci; 2019 Aug; 19(7):994-1003. PubMed ID: 30732555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis.
    Spahis S; Delvin E; Borys JM; Levy E
    Antioxid Redox Signal; 2017 Apr; 26(10):519-541. PubMed ID: 27452109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease.
    Liu W; Baker SS; Baker RD; Zhu L
    Curr Drug Targets; 2015; 16(12):1301-14. PubMed ID: 25915484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
    Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
    World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.
    Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T
    Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease.
    Jorgačević B; Mladenović D; Ninković M; Prokić V; Stanković MN; Aleksić V; Cerović I; Vukićević RJ; Vučević D; Stanković M; Radosavljević T
    Hum Exp Toxicol; 2014 Jul; 33(7):701-9. PubMed ID: 24130212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of vitamin E in nonalcoholic fatty liver disease.
    Nagashimada M; Ota T
    IUBMB Life; 2019 Apr; 71(4):516-522. PubMed ID: 30592129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.
    Chen Z; Tian R; She Z; Cai J; Li H
    Free Radic Biol Med; 2020 May; 152():116-141. PubMed ID: 32156524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress.
    Li C; Liu Q; Xie L
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):22-29. PubMed ID: 30454891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
    Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
    J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease.
    Wang J; He W; Tsai PJ; Chen PH; Ye M; Guo J; Su Z
    Lipids Health Dis; 2020 Apr; 19(1):72. PubMed ID: 32284046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship.
    Karkucinska-Wieckowska A; Simoes ICM; Kalinowski P; Lebiedzinska-Arciszewska M; Zieniewicz K; Milkiewicz P; Górska-Ponikowska M; Pinton P; Malik AN; Krawczyk M; Oliveira PJ; Wieckowski MR
    Eur J Clin Invest; 2022 Mar; 52(3):e13622. PubMed ID: 34050922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
    Pierantonelli I; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.